Showing results (61-70 of 82) with videos related to
Sort By:
Pageof 9
Annals of the New York Academy of Sciences|February 1, 2005
New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonistsNigel H Greig, Mark P Mattson, Tracyann Perry, et al.Neurobiology of Disease|March 7, 2006
Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levelsJavier Pacheco-Quinto, Elena B Rodriguez de Turco, Steven DeRosa, et al.The Journal of Pharmacology and Experimental Therapeutics|May 13, 2006
Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-beta peptideTada Utsuki, Qian-Sheng Yu, Diane Davidson, et al.Journal of Alzheimer'S Disease : JAD|September 22, 2006
Neurine, an acetylcholine autolysis product, elevates secreted amyloid-beta protein precursor and amyloid-beta peptide levels, and lowers neuronal cell viability in culture: a role in Alzheimer's disease?David Tweedie, Arnold Brossi, DeMoa Chen, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisDebomoy K Lahiri, Ruizhi Wang, Bryan Maloney, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumDebomoy K Lahiri, Ruizhi Wang, Bryan Maloney, et al.Acta Neurobiologiae Experimentalis|June 12, 2004
Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseasesNigel H Greig, Tony Giordano, Xiaoxiang Zhu, et al.Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|January 31, 2013
Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-Synuclein synthesis, interleukin-1β release, and cholinergic actionQian-Sheng Yu, Marcella Reale, Mohammad A Kamal, et al.Journal of Neurochemistry|February 16, 2011
Targets for AD treatment: conflicting messages from γ-secretase inhibitorsKumar Sambamurti, Nigel H Greig, Tadanobu Utsuki, et al.Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP/PS1 mouseAndrew F Teich, Ekta Sharma, Eliza Barnwell, et al.Pageof 9